DP190102950/Australian Research Council[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2022	1
2023	2
2024	3
2025	0

Page 1

Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders.

Saito A, Alvi S, Valant C, Christopoulos A, Carbone SE, Poole DP. Saito A, et al. Br J Pharmacol. 2024 Jul;181(14):2232-2246. doi: 10.1111/bph.16023. Epub 2023 Jan 18. Br J Pharmacol. 2024. PMID: 36565295 Review.

Opportunities and challenges for the development of M₁ muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits.

Nguyen HTM, van der Westhuizen ET, Langmead CJ, Tobin AB, Sexton PM, Christopoulos A, Valant C. Nguyen HTM, et al. Br J Pharmacol. 2024 Jul;181(14):2114-2142. doi: 10.1111/bph.15982. Epub 2022 Dec 4. Br J Pharmacol. 2024. PMID: 36355830 Review.

Importance of receptor expression in the classification of novel ligands at the M₂ muscarinic acetylcholine receptor.

Jiang Y, Yeasmin M, Gondin AB, Christopoulos A, Valant C, Burger WAC, Thal DM. Jiang Y, et al. Br J Pharmacol. 2024 Jul;181(14):2338-2350. doi: 10.1111/bph.16021. Epub 2023 Jan 20. Br J Pharmacol. 2024. PMID: 36550621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year